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Abstract
Purpose: Recent studies have implicated the human cytomegalovirus (HCMV) as a possible pathogen for causing
hypertension. We aimed to study the association between HCMV infection and hypertension in the United States National
Health and Nutrition Examination Survey (NHANES).
Methods: We analyzed data on 2979 men and 3324 women in the NHANES 1999–2002. We included participants aged 16–
49 years who had valid data on HCMV infection and hypertension.
Results: Of the participants, 54.7% had serologic evidence of HCMV infection and 17.5% had hypertension. There were
ethnic differences in the prevalence of HCMV infection (P,0.001) and hypertension (P,0.001). The prevalence of both
increased with age (P,0.001). Before adjustment, HCMV seropositivity was significantly associated with hypertension in
women (OR=1.63, 95% CI=1.25–2.13, P=0.001) but not in men. After adjustment for race/ethnicity, the association
between HCMV seropositivity and hypertension in women remained significant (OR=1.55, 95% CI=1.20–2.02, P=0.002).
Further adjustment for body mass index, diabetes status and hypercholesterolemia attenuated the association (OR=1.44,
95% CI=1.10–1.90, P=0.010). However, after adjusting for age, the association was no longer significant (OR=1.24, 95%
CI=0.91–1.67, P=0.162).
Conclusions: In this nationally representative population-based survey, HCMV seropositivity is associated with hypertension
in women in the NHANES population. This association is largely explained by the association of hypertension with age and
the increase in past exposure to HCMV with age.
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Introduction
Hypertension, a multi-factorial disease, is a global public health
burden. [1,2] It is a predisposing risk factor for myocardial
infarction, revascularization, heart failure, stroke and renal failure.
Both genetic and environmental factors are involved in the
development of hypertension. There are many known environ-
mental factors leading to hypertension. Obesity, inappropriate
diet, stress, lack of physical activity, tobacco smoking, alcoholic
drinking and certain medications are known risk factors for
hypertension. [3] In recent years, meta-analysis of genome wide
association studies has highlighted a number of genetic variants
associated with hypertension. [4].
Human cytomegalovirus (HCMV), a member of the beta herpes
virus family, is a ubiquitous pathogen that infects only humans. [5]
It is an opportunistic infection in 90% of the HIV carriers and
a latent infection in over 50% of the general population. [6]
Although HCMV infection is usually asymptomatic in healthy
adults, it can infect organs and tissues virtually throughout the
body. HCMV is a cause of congenital diseases, causes primary
infection in children and young adults, and has been implicated in
pneumonitis, retinitis and gastroenteritis in adults, particularly in
immunosuppressed or immunocompromised patients, such as
transplant recipients and patients with HIV infection. [7].
RecentstudieshavesuggestedthatHCMV infectionisassociated
with a significantly increased risk for all-cause and cardiovascular
diseases (CVDs) related mortality. [8] It has been implicated in
endothelial dysfunction [9] and different cardiovascular diseases,
such as myocarditis, atherosclerosis and coronary artery disease.
[10,11,12] However the association between HCMV infection and
hypertension is still unclear. [13] As hypertension is an important
cause of CVDs, we studied the association between HCMV and
hypertension in the United States (US) National Health and
Nutrition Examination Survey (NHANES) 1999–2002.
Methods
Study Population
For this analysis, data were extracted from NHANES 1999–
2002, which was a continuous survey since 1999. The study
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Prevention Institutional Review Board. All participants gave
written consent for their information to be stored in the
database and used for research. They also gave written consent
for their blood and urine samples to be kept for future research,
such as the measurement of HCMV specific IgG. For
participants aged 16–17 years, written consent was obtained
both from them and their parents or guardians. Participants
were examined in well-equipped mobile examination centers
located around the US. The detailed measurement procedures
and protocols have been described in previous publications and
also on its website. [14] Participants were selected using
a stratified, multistage probability sampling design from the
civilian non-institutionalized US population. Among the 6610
participant aged $16 years who had valid data on HCMV
infection and hypertension, 6303 participants with valid data on
body mass index (BMI), blood pressure, diabetes and hyper-
cholesterolemia were included in our study.
Variables of Interest
Race/ethnicity was based on self-reported questionnaires.
Participants were classified as non-Hispanic whites, non-
Hispanic blacks, Mexican Americans and others. HCMV
infection status was determined by HCMV specific IgG test
using commercial enzyme linked immunosorbent assay (ELISA)
kits (Quest International Inc, Miami, FL) in a centralized
manner. Sera with values near the ELISA cutoff (approximately
5.2% of total) were measured again with another commercial
ELISA kit (bioMerieux Inc, Durham, NC) to confirm the
results. An immunofluorescence assay (Bion International Inc,
Park Ridge, IL), was used to give the final results if the results
from the first two tests disagreed (approximately 2.7% of total).
The optical density from the ELISA assay was reported as an
approximate measure of antibody titer. A low and positive
optical density reflects a low antibody titer and a high optical
density reflects a high antibody titer. BMI was calculated as the
weight in kilograms divided by the square of the height in
meters. Blood pressure was measured manually by a trained
operator using a mercury sphygmomanometer. Hypertension
was defined as self-report of diagnosed hypertension, blood
pressure $140/90 mm Hg, or use of anti-hypertensive medica-
tions. Diabetes was defined as a fasting glucose of $7.0 mmol/
L (126 mg/dl), non-fasting glucose of $11.1 mmol/L (200 mg/
dl), previous diagnosis by a doctor, or use of anti-diabetic
medications. Hypercholesterolemia was defined as total serum
cholesterol $240 mg/dL, previous diagnosis by a doctor, or
taking prescribed medicine for hypercholesterolemia.
Statistical Analysis
Data were analyzed using the complex sampling function of
SPSS version 20.0 (IBM Corporation, Armonk, NY). The four-
year mobile examination weight was used in all analyses to
account for non-response bias, and the oversampling of blacks,
Mexican Americans and the elderly in NHANES 1999–2002 so
that the estimates were nationally representative according to the
2000 US Census population. P values were obtained using logistic
or multiple regression analysis where appropriate, using the
complex sampling function. Logistic and multiple regressions were
used to adjust for covariates. Variables that significantly differed
between participants with and without HCMV infection, or with
and without hypertension, were used as covariates in the
regression models. There was no significant interaction between
HCMV seropositivity and race/ethnicity with hypertension in
multiple regression analysis. Therefore all the racial/ethnic groups
were combined for analysis.
Results
Among the 6303 participants aged 16–49 years in NHANES
1999–2002, 3975 had HCMV infection (54.761.3%) and 939 had
hypertension (17.560.8%). All the percentages were calculated
after weighting to the 2000 US Census population.
Table 1 shows the characteristics of all participants according to
HCMV seropositivity status. Participants with HCMV infection
were older (P,0.001) and more likely to be women (P,0.001),
compared to participants without HCMV infection. There were
significant racial/ethnic differences between participants with and
without HCMV infection (P,0.001).
Table 2 shows the characteristics of all participants according to
hypertension status. Participants with hypertension were older
(P,0.001) and had a greater BMI (P,0.001), compared to
participants without hypertension. Also hypertensive participants
were more likely to be men (P=0.004), and have diabetes
(P,0.001) as well as hypercholesterolemia (P,0.001). There were
significant racial/ethnic differences between participants with and
without hypertension (P,0.001).
Figure 1 shows univariate logistic regression analysis of
hypertension. In this analysis, HCMV seropositivity was associated
with hypertension in women (OR=1.63, 95% CI=1.25–2.13,
P=0.001) but the association in men was not significant
(OR=0.94, 95% CI=0.75–1.20, P=0.620).
Table 3 shows the logistic regression analysis after adjusting for
covariates. There was no significant association between HCMV
seropositivity and hypertension in men in any of the models. The
association between HCMV seropositivity and hypertension in
women remained significant after adjusting for race/ethnicity
Table 1. Clinical characteristics of all 6303 subjects among
subjects with and without serologic evidence of HCMV
infection.
Characteristics
HCMV
infection
No HCMV
infection P
n 3975 2328
Age, years 34.0(0.3) 32.1(0.3) ,0.001
Men, % 44.3(1.2) 56.1(1.0) ,0.001
BMI, kg/m
2 27.5(0.2) 27.1(0.2) 0.156
Race/ethnicity, %
Non-Hispanic white 52.8(2.2) 82.6(1.3) ,0.001
Non-Hispanic black 16.2(1.9) 5.9(0.7)
Mexican American 14.3(1.5) 3.5(0.6)
Others 16.7(2.4) 8.0(1.2)
Diabetes, % 3.6(0.4) 2.8(0.5) 0.189
Hypercholesterolemia, % 21.5(0.7) 20.6(1.0) 0.456
Hypertension, % 18.3(1.0) 16.4(1.2) 0.179
SBP, mmHg* 115.6(0.5) 115.9(0.5) 0.575
DBP, mmHg* 71.8(0.4) 71.5(0.4) 0.563
Data are expressed as mean or percent (SE). BMI, body mass index. SBP, systolic
blood pressure. DBP, diastolic blood pressure.
*241 subjects taking anti-hypertensive medication were excluded from the
analysis (n=165 for HMCV infection group and n=76 for no HCMV infection
group).
doi:10.1371/journal.pone.0039760.t001
HCMV Infection and Hypertension
PLoS ONE | www.plosone.org 2 July 2012 | Volume 7 | Issue 7 | e39760(OR=1.55, 95% CI=1.20–2.02, P=0.002). Further adjustment
for BMI, diabetes status and hypercholesterolemia attenuated the
association (OR=1.44, 95% CI=1.10–1.90, P=0.010). Howev-
er, after adjusting for age, the association was no longer significant
(OR=1.24, 95% CI=0.91–1.67, P=0.162).
Table 4 shows the association between optical density for the
HCMV specific IgG assay and blood pressure as a continuous
variable among participants who were not taking any antihy-
pertensive medication. In men, there was no significant
relationship between optical density for the HCMV specific
IgG assay and systolic or diastolic blood pressure before
adjustment (P=0.144). After adjusting for race/ethnicity, there
is a significant association between optical density for the
HCMV specific IgG assay and diastolic blood pressure
(P=0.033). Further adjustment for body mass index, diabetes
status and hypercholesterolemia did not attenuate the associa-
tion (P=0.029). However, after adjusting for age, the associa-
tion was no longer significant (P=0.815). In contrast, optical
density for the HCMV specific IgG assay was associated with
both systolic and diastolic blood pressure in women, but this
association was no longer significant after controlling for age.
The conclusions remained the same if we included participants
on antihypertensive medication but added 10/5 mmHg to their
blood pressure on treatment. [15].
Discussion
Our study used data from the large and nationally represen-
tative NHANES study to investigate the association between
HCMV and hypertension. It shows that there is no strong
evidence to support HCMV as a significant cause of hypertension.
Although HCMV seropositivity was significantly associated with
hypertension in women, the association was greatly diminished
after adjusting for age. This means that the association of
hypertension with HCMV seropositivity in women can largely
be explained by the increased likelihood of having had HCMV
infection with age. A similar trend also appeared in the association
between HCMV seropositivity and diastolic blood pressure in
men. A previous study involving 1074 women and 857 men (aged
24–39 years) from the Cardiovascular Risk in Young Finns study
has shown that CMV antibody titers were independent determi-
nants for systolic and diastolic blood pressure elevation and flow-
mediated dilation in men, but not in women. Discrepancies
between the Cardiovascular Risk in Young Finns Study and our
study might be due to differences in sample size, age range,
socioeconomic factors, dietary habits and climate. [16] However,
our study has the advantages of having a larger sample size, wider
age range and several racial/ethnic groups.
Although no strong evidence that HCMV is a significant cause
of hypertension has been found in clinical studies, there is
a theoretical basis for this association and several mechanisms can
be envisaged. First, HCMV infection could lead to oxidative stress
and endothelial dysfunction. [9,11,17,18,19,20] As endothelial
dysfunction and inflammation are two key mechanisms in the
development and progression of hypertension, [21,22] this
provides an explanation of how chronic HCMV infection may
result in hypertension. Second, HCMV infection triggers the
proliferation of one type of T lymphocytes, CD8+ cytotoxic T
lymphocytes. [23,24] The clonal expansion of HCMV-specific T
Table 2. Clinical characteristics of all 6303 subjects among
subjects with and without hypertension.
Characteristics Hypertension No Hypertension P
n 939 5364
Age, years 38.0(0.5) 32.1(0.3) ,0.001
Men, % 56.4(2.5) 48.2(0.9) 0.004
BMI, kg/m
2 31.5(0.3) 26.4(0.1) ,0.001
Race/ethnicity, %
Non-Hispanic white 64.2(2.1) 66.8(1.9) ,0.001
Non-Hispanic black 17.3(2.2) 10.3(1.2)
Mexican American 7.1(1.1) 9.9(1.1)
Others 11.3(1.9) 13.1(1.9)
Diabetes, % 8.6(1.2) 2.1(0.3) ,0.001
Hypercholesterolemia, % 40.7(2.4) 16.9(0.6) ,0.001
HCMV, % 57.4(2.3) 54.1(1.4) 0.179
SBP, mmHg* 129.9(0.9) 112.7(0.3) ,0.001
DBP, mmHg* 81.4(0.7) 69.6(0.2) ,0.001
Data are expressed as mean or percent (SE). BMI, body mass index. SBP, systolic
blood pressure. DBP, diastolic blood pressure.
*241 subjects taking anti-hypertensive medication were excluded from the
analysis (n=165 for HMCV infection group and n=76 for no HCMV infection
group).
doi:10.1371/journal.pone.0039760.t002
Figure 1. Percentage of HCMV seropositivity in participants with and without hypertension before adjustment. HT, hypertension.
doi:10.1371/journal.pone.0039760.g001
Table 3. Association of HCMV seropositivity with
hypertension in men and women.
Model 1 Model 2 Model 3
Men
OR 0.96 1.00 0.93
95%CI 0.75–1.23 0.77–1.30 0.71–1.21
Women
OR 1.55 1.44 1.24
95%CI 1.20–2.02 1.10–1.90 0.91–1.67
P 0.002 0.010 0.162
Model 1: adjusted for race/ethnicity (non-Hispanic white, non-Hispanic black,
Mexican Americans, and others).
Model 2: further adjusted for BMI, diabetes and hypercholesterolemia.
Model 3: further adjusted for age.
doi:10.1371/journal.pone.0039760.t003
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known that T lymphocytes take part in the alteration of vascular
tone encountered hypertension induced by angiotensin II, which is
a potent vasoconstrictor. [25] Therefore, T cells may be a link
between HCMV infection and hypertension. Third, recent
research has suggested that microRNAs (miRNAs), a class of
post-transcriptional gene expression regulators, are present in the
circulation and may serve as potential biomarkers. [26] From
a genetic point of view, circulating miRNAs carry disease-specific
information owing to inherent genomic alterations. A recent study
showed HCMV infection was significantly correlated with the
miRNA (hcmv-miRUL112) which is encoded by HCMV and
highly expressed in hypertensive patients compared to healthy
control subjects. [27] This suggested a possible link between
HCMV infection and hypertension at the genomic level as well.
Fourth, mouse cytomegalovirus (MCMV), the animal counterpart
of HCMV, has been demonstrated to activate over-expression of
angiotensin II in the renin-angiotensin-aldosterone system
(RAAS), which plays an important part in the emergence of
hypertension. [28] Angiotensin II causes vasoconstriction, and also
stimulates generation and secretion of ROS, inflammatory
cytokines, chemokines and adhesion molecules. [29] Therefore it
is possible that HCMV has similar effects on the human RAAS, so
further research to elucidate the role of HCMV in hypertension is
still needed.
This study has provided some important insights into HCMV
and hypertension. The results derived from a large nationally-
representative population are reliable due to good sampling design
and quality control. It shows that age may account for a large part
of the association of HCMV infection with hypertension. Some
risk factors known to be closely related to hypertension, such as
alcohol consumption, smoking and physical activity, contribute to
the development and progression of hypertension. In this study, we
did not include these factors as covariates in the adjustment of the
association of HCMV with hypertension because there were
a substantial number of subjects with missing values in these
factors in the NHANES database. Incorporating these risk factors
in our model would have reduced the sample size and thereby the
power of our analysis. Further studies with larger sample sizes and
more comprehensive information on risk factors are needed to
elucidate the complex relationship between HCMV and hyper-
tension.
In conclusion, HCMV seropositivity is associated with hyper-
tension in women in the NHANES population. This association is
largely explained by the association of hypertension with age and
the increase in past exposure to HCMV with age.
Author Contributions
Conceived and designed the experiments: BMYC. Analyzed the data: CL.
Wrote the paper: CL NRS KLO HKW BMYC. Gave advice on the
analysis: BMYC KLO NRS.
References
1. Cheung BMY, Ong KL (2011) The Challenge of Managing Hypertension. In:
Finkel ML, Westport CT, editors. Public health in the 21st century. Praeger
Press. 117–128.
2. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS (2007) Prevalence,
awareness, treatment, and control of hypertension among United States adults
1999–2004. Hypertension 49: 69–75.
3. Chaturvedi S (2004) The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC
7): is it really practical? Natl Med J India 17: 227.
4. Taal HR, Verwoert GC, Demirkan A, Janssens AC, Rice K, et al. (2012)
Genome-Wide Profiling of Blood Pressure in Adults and Children. Hypertension
59: 241–247.
5. Crough T, Khanna R (2009) Immunobiology of human cytomegalovirus: from
bench to bedside. Clin Microbiol Rev 22: 76–98, Table of Contents.
6. Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the
United States: the national health and nutrition examination surveys, 1988–
2004. Clin Infect Dis 50: 1439–1447.
7. Martin JM, Danziger-Isakov LA (2011) Cytomegalovirus risk, prevention, and
management in pediatric solid organ transplantation. Pediatr Transplant 15:
229–236.
8. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, et al. (2011)
Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular
disease-related mortality in the United States. PLoS One 6: e16103.
9. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, et al.
(2003) Human cytomegalovirus seropositivity is associated with impaired
vascular function. Circulation 108: 678–683.
10. Kyto V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, et al. (2005)
Cytomegalovirus infection of the heart is common in patients with fatal
myocarditis. Clin Infect Dis 40: 683–688.
11. Grahame-Clarke C (2005) Human cytomegalovirus, endothelial function and
atherosclerosis. Herpes 12: 42–45.
12. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart
disease: is there a link? Lancet 350: 430–436.
13. Zhang M, Yang Y, Yang X, Cai J (2011) Human cytomegalovirus infection is
a novel etiology for essential hypertension. Med Hypotheses 76: 682–684.
14. Centers for Disease Control and Prevention (CDC). National Center for Health
Statistics (NCHS): National Health and Nutrition Examination Survey
questionnaire, examination protocol and laboratory protocol. Hyattsville,
Maryland: United States Department of Health and Human Services, Centers
for Disease Control and Prevention, 1999–2002. Available: http://www.cdc.
gov/nchs/nhanes.htm. Accessed 2011 Nov 30.
15. Cui JS, Hopper JL, Harrap SB (2003) Antihypertensive treatments obscure
familial contributions to blood pressure variation. Hypertension 41: 207–210.
16. Haarala A, Kahonen M, Lehtimaki T, Aittoniemi J, Jylhava J, et al. (2012)
Relation of high cytomegalovirus antibody titres to blood pressure and brachial
artery flow-mediated dilation in young men: the Cardiovascular Risk in Young
Finns Study. Clin Exp Immunol 167: 309–316.
17. Shen YH, Zhang L, Utama B, Wang J, Gan Y, et al. (2006) Human
cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating
PTEN (phosphatase and tensin homolog deleted on chromosome 10).
Cardiovascular Research 69: 502–511.
18. Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, et al. (2004)
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of
asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 109:
500–505.
19. Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, et al. (2004)
Cytomegalovirus infection in heart transplant recipients is associated with
impaired endothelial function. Circulation 110: II207–212.
Table 4. Association of optical density for the HCMV specific
IgG assay with blood pressure in men and women.
Systolic Blood Pressure Diastolic Blood Pressure
BPB P
Men (N=2874)
Unadjusted 20.133 0.635 0.425 0.144
Model 1 20.327 0.249 0.661 0.033
Model 2 20.291 0.309 0.643 0.029
Model 3 20.449 0.095 0.067 0.815
Women (N=3188)
Unadjusted 0.794 0.006 0.638 0.003
Model 1 0.681 0.019 0.772 0.001
Model 2 0.393 0.137 0.630 0.004
Model 3 20.181 0.484 0.050 0.813
Model 1: adjusted for race/ethnicity (non-Hispanic white, non-Hispanic black,
Mexican Americans, and others).
Model 2: further adjusted for BMI, diabetes and hypercholesterolemia.
Model 3: further adjusted for age.
doi:10.1371/journal.pone.0039760.t004
HCMV Infection and Hypertension
PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e3976020. Poole E, Atkins E, Nakayama T, Yoshie O, Groves I, et al. (2008) NF-kappaB-
mediated activation of the chemokine CCL22 by the product of the human
cytomegalovirus gene UL144 escapes regulation by viral IE86. J Virol 82: 4250–
4256.
21. Wong WT, Wong SL, Tian XY, Huang Y (2010) Endothelial Dysfunction: The
Common Consequence in Diabetes and Hypertension. Journal of Cardiovas-
cular Pharmacology 55: 300–307.
22. Savoia C, Schiffrin EL (2007) Vascular inflammation in hypertension and
diabetes: molecular mechanisms and therapeutic interventions. Clinical Science
112: 375–384.
23. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, et al. (1996) The
human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated
by structural protein pp65: frequency, specificity, and T-cell receptor usage of
pp65-specific CTL. J Virol 70: 7569–7579.
24. Fuhrmann S, Streitz M, Reinke P, Volk HD, Kern F (2008) T cell response to
the cytomegalovirus major capsid protein (UL86) is dominated by helper cells
with a large polyfunctional component and diverse epitope recognition. J Infect
Dis 197: 1455–1458.
25. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, et al. (2007) Role of
the T cell in the genesis of angiotensin II induced hypertension and vascular
dysfunction. J Exp Med 204: 2449–2460.
26. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M (2011) Profiling of
circulating microRNAs: from single biomarkers to re-wired networks. Cardio-
vascular Research.
27. Li S, Zhu J, Zhang W, Chen Y, Zhang K, et al. (2011) Signature microRNA
expression profile of essential hypertension and its novel link to human
cytomegalovirus infection. Circulation 124: 175–184.
28. Cheng J, Ke Q, Jin Z, Wang H, Kocher O, et al. (2009) Cytomegalovirus
infection causes an increase of arterial blood pressure. PLoS Pathog 5:
e1000427.
29. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, et al. (2000)
Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and
cytokine induction. Circ Res 87: 1195–1201.
HCMV Infection and Hypertension
PLoS ONE | www.plosone.org 5 July 2012 | Volume 7 | Issue 7 | e39760